April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
A Comparison of the Effectiveness of Soaking Acrylic Hydrophilic and Acrylic Hydrophobic Intraocular Lenses in Moxifloxacin 0.5%
Author Affiliations & Notes
  • J. W. Shaw
    SUNY Downstate Dept of Ophthalmology, Brooklyn, New York
    Department of Veterans Affairs, New York Harbor Healthcare System, Brooklyn, New York
  • A. El-Bash
    SUNY Downstate Dept of Ophthalmology, Brooklyn, New York
    Department of Veterans Affairs, New York Harbor Healthcare System, Brooklyn, New York
  • M. Gaffar
    SUNY Downstate Dept of Ophthalmology, Brooklyn, New York
    Department of Veterans Affairs, New York Harbor Healthcare System, Brooklyn, New York
  • R. A. Prince
    Anti-Infective Research Lab, University of Houston, Houston, Texas
  • A. Schrier
    Harkness Eye Institute, New York Presbyterian Hospital, Columbia University, New York, New York
  • E. F. Smith
    SUNY Downstate Dept of Ophthalmology, Brooklyn, New York
    Department of Veterans Affairs, New York Harbor Healthcare System, Brooklyn, New York
  • Footnotes
    Commercial Relationships  J.W. Shaw, None; A. El-Bash, None; M. Gaffar, None; R.A. Prince, None; A. Schrier, None; E.F. Smith, Alcon Inc., F.
  • Footnotes
    Support  Alcon Inc.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2901. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. W. Shaw, A. El-Bash, M. Gaffar, R. A. Prince, A. Schrier, E. F. Smith; A Comparison of the Effectiveness of Soaking Acrylic Hydrophilic and Acrylic Hydrophobic Intraocular Lenses in Moxifloxacin 0.5%. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2901.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the levels of moxifloxacin achieved in an artificial anterior chamber by soaking the hydrophobic acrylic AcrySof® SA60 (Alcon Inc.) IOL and the hydrophilic collamer AfinityTM CQ2015 (Staar) IOL in commercially available moxifloxacin 0.5% (Vigamox®, Alcon Inc.). The lenses were soaked for either 1 minute or 10 minutes.

Methods: : 40 IOLs (20 SA60 and 20 CQ2015) were soaked in 1 cc of commercially available moxifloxacin 0.5%. Ten of each for 1 minute, and ten of each for 10 minutes. The IOLs were patted dry with absorbent pads (BD Biosciences) and placed in vials of 10 cc Balanced Salt Solution (BSS) for 30 minutes. 5 cc of the BSS were removed and analyzed by High Pressure Liquid Chromatography (HPLC) to determine the antibiotic levels achieved.

Results: : The moxifloxacin levels achieved after soaking the CQ2015 lens were 0.283 µg/ml and 0.717 µg/ml for 1 and 10 minute soaks, respectively. The moxifloxacin levels achieved after soaking the SA60 lens were 0.238 µg/ml and 0.342 µg/ml for 1 and 10 minute soaks, respectively.

Conclusions: : The hydrophilic lens was a more efficient delivery system than the hydrophobic lens. Both lenses were capable of delivering clinically significant antibiotic levels after a 1 minute soak. Moxifloxacin concentrations reached at both one minute and ten minute soak times exceed the MIC90 of the most common pathogens responsible for post-operative endophthalmitis, Staphylococcus epidermidis (0.13 µg/ml), Staphylococcus aureus (0.06 µg/ml), and Haemophilus influenzae (0.06 µg/ml). Levels from the 10 minute soak of SA60 and both times for CQ2015 also exceeded the MIC90 for Streptococcus spp (0.25 µg/ml) and Proteus mirabilis (0.25 µg/ml). Current prophylaxis practice includes isolation of the eyelids and lashes, topical betadine, and pre- and post-operative topical antibiotics. The antibiotic-soaked IOL has potential to become a clinically significant technique in the prevention of postoperative endophthalmitis.

Keywords: intraocular lens • endophthalmitis • antibiotics/antifungals/antiparasitics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×